This study explores the sensitivity of acute myelogenous leukemia (AML) cells to agents that target glutathione metabolism. It found that CD34+ AML cells exhibited higher expression of glutathione pathway proteins compared to normal cells, resulting in altered glutathione levels. The use of parthenolide (PTL) effectively depleted glutathione in AML cells,
